Kun Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kun Zhang has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Peibiao Mai
Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences (Shenzhen Sun Yat-Sen Cardiovascular Hospital), Shenzhen, China
6 shared publicationsSijin Li
Department of Cardiology, Joint Laboratory of Guangdong-Hong Kong-Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China
4 shared publications- Chao Tong
School of Computer Science and Engineering, Beihang University, Beijing, China
3 shared publications Shuwan Xu
Department of Cardiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
3 shared publicationsYuanting Zhu
Department of Cardiology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China
3 shared publicationsYuqi Zhang
School of Computer Science & Engineering, Beihang University, Beijing, China
3 shared publications
Latest Publications
- Open Access
- 12 September 2026
- Published by Springer Nature in Biology Direct
The role of SLC16A11 in the survival and immune infiltrates of lung adenocarcinoma (LUAD) patients
- 12 September 2026
- Published by Springer Nature in Biology Direct
Open AccessThe role of SLC16A11 in the survival and immune infiltrates of lung adenocarcinoma (LUAD) patients
- Open Access
- 13 June 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 170, 108881
Hemorrhagic eosinophilic pericardial effusion associated with probable sparganosis
- 13 June 2026
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 170, 108881
Open AccessHemorrhagic eosinophilic pericardial effusion associated with probable sparganosis
- Open Access
- 24 January 2026
- Published by Springer Nature in BioData Mining
- Vol. 19 (1)
An online non-radiographic osteoporosis prediction calculator constructed using interpretable machine learning
Osteoporosis represents a major health challenge in aging populations, yet its diagnosis largely depends on dual-energy X-ray absorptiometry (DXA), which i
- 24 January 2026
- Published by Springer Nature in BioData Mining
- Vol. 19 (1)
Open AccessAn online non-radiographic osteoporosis prediction calculator constructed using interpretable machine learning
Osteoporosis represents a major health challenge in aging populations, yet its diagnosis largely depends on dual-energy X-ray absorptiometry (DXA), which i
- Open Access
- 26 September 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-9
Acute myocardial injury induced by pheochromocytoma: a case report
Pheochromocytomas (PCC) are neuroendocrine tumors derived from neural crest cells. PCC typically develop within the adrenal medulla and are known for their catecholamine hypersecretion, leading to acute myocardial injuries and cardiac dysfunction, such as acute heart failure, pulmonary embolism, cardiogenic shock, and tachyarrhythmia. In the clinic, the rarity of these conditions often results in diagnostic challenges, which can delay crucial treatment interventions. A 37-year-old woman presented with headache, chest discomfort, hypertension, and was detected myocardial injury. Chest computed tomography revealed a mass inside the left adrenal limb. The elevation of methoxy-catecholamines in urine confirmed the diagnosis of PCC. After a left adrenal mass resection, the plasma catecholamine level was recovery to normal. At the telephone follow-up, the patient complained of occasional episodes of palpitation, but no pain or other discomfort. We present a case of acute myocardial injury caused by PCC and conduct a relevant literature review to provide experience for the clinic. In young patients lacking cardiovascular risk factors presenting with episodes of hypertension and chest tightness, it is recommended to perform CT imaging to differentiate between PCC and cardiovascular diseases. All patients with PCC are advised to refine genetic testing.
- 26 September 2025
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 1-9
Open AccessAcute myocardial injury induced by pheochromocytoma: a case report
Pheochromocytomas (PCC) are neuroendocrine tumors derived from neural crest cells. PCC typically develop within the adrenal medulla and are known for their catecholamine hypersecretion, leading to acute myocardial injuries and cardiac dysfunction, such as acute heart failure, pulmonary embolism, cardiogenic shock, and tachyarrhythmia. In the clinic, the rarity of these conditions often results in diagnostic challenges, which can delay crucial treatment interventions. A 37-year-old woman presented with headache, chest discomfort, hypertension, and was detected myocardial injury. Chest computed tomography revealed a mass inside the left adrenal limb. The elevation of methoxy-catecholamines in urine confirmed the diagnosis of PCC. After a left adrenal mass resection, the plasma catecholamine level was recovery to normal. At the telephone follow-up, the patient complained of occasional episodes of palpitation, but no pain or other discomfort. We present a case of acute myocardial injury caused by PCC and conduct a relevant literature review to provide experience for the clinic. In young patients lacking cardiovascular risk factors presenting with episodes of hypertension and chest tightness, it is recommended to perform CT imaging to differentiate between PCC and cardiovascular diseases. All patients with PCC are advised to refine genetic testing.
- Open Access
- 3 February 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1-15
A machine learning-based model for predicting paroxysmal and persistent atrial fibrillation based on EHR
There is no effective way to accurately predict paroxysmal and persistent atrial fibrillation (AF) subtypes unless electrocardiogram (ECG) observation is obtained. We aim to develop a predictive model using a machine learning algorithm for identification of paroxysmal and persistent AF, and investigate the influencing factors. We collected demographic data, medication use, serological indicators, and baseline cardiac ultrasound data of all included subjects, totaling 50 variables. The diagnosis of AF subtypes is confirmed by ECG observation for at least more than 7 days. Variable selection was performed by spearman correlation analysis, recursive feature elimination, and least absolute shrinkage and selection operator regression. We built a prediction model for AF using three machine learning methods. Finally, the significance of each variable was analyzed by Shapley additive explanations method. After screening, we found the optimal variable set consisting of 10 variables. The model we built achieved good predictive performance (AUC = 0.870, 95%CI 0.858 to 0.882), and had specificity of 0.851 (95%CI 0.844 to 0.858) and sensitivity of 0.716 (95%CI 0.676 to 0.755). Good predictive performance was stably achieved in different age subgroups and different gender subgroups. LA and NT-proBNP were the two most important variables for predicting paroxysmal and persistent AF in all models, except for the female subgroup aged less than 60 years. Our model makes it possible to predict paroxysmal and persistent AF based on baseline data at admission. Early and individualized intervention strategies based on our model may help to improve clinical outcomes in AF patients.
- 3 February 2025
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 25 (1) , 1-15
Open AccessA machine learning-based model for predicting paroxysmal and persistent atrial fibrillation based on EHR
There is no effective way to accurately predict paroxysmal and persistent atrial fibrillation (AF) subtypes unless electrocardiogram (ECG) observation is obtained. We aim to develop a predictive model using a machine learning algorithm for identification of paroxysmal and persistent AF, and investigate the influencing factors. We collected demographic data, medication use, serological indicators, and baseline cardiac ultrasound data of all included subjects, totaling 50 variables. The diagnosis of AF subtypes is confirmed by ECG observation for at least more than 7 days. Variable selection was performed by spearman correlation analysis, recursive feature elimination, and least absolute shrinkage and selection operator regression. We built a prediction model for AF using three machine learning methods. Finally, the significance of each variable was analyzed by Shapley additive explanations method. After screening, we found the optimal variable set consisting of 10 variables. The model we built achieved good predictive performance (AUC = 0.870, 95%CI 0.858 to 0.882), and had specificity of 0.851 (95%CI 0.844 to 0.858) and sensitivity of 0.716 (95%CI 0.676 to 0.755). Good predictive performance was stably achieved in different age subgroups and different gender subgroups. LA and NT-proBNP were the two most important variables for predicting paroxysmal and persistent AF in all models, except for the female subgroup aged less than 60 years. Our model makes it possible to predict paroxysmal and persistent AF based on baseline data at admission. Early and individualized intervention strategies based on our model may help to improve clinical outcomes in AF patients.
- Top Cited PapersOpen Access
- 1 February 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 2465-2481
Identification of Necroptosis and Immune Infiltration in Heart Failure Through Bioinformatics Analysis
Purpose: Heart failure (HF) remains a leading cause of mortality and morbidity in cardiovascular disease. Research has shown that necroptosis contributes to HF, and immune infiltration has been reported to be implicated in HF. However, the specific mechanisms by which necroptosis and immune infiltration promote HF remain poorly understood. This study aims to elucidate these mechanisms, thereby providing new insights for future therapeutic strategies. Methods and Results: In the GSE21610 dataset, there were 1848 differentially expressed genes (DEGs), 14 of which related to necroptosis (NRDEGs) in HF. Gene Set Enrichment Analysis (GSEA) indicated that Th1 and Th2 cell differentiation, TGF-beta signaling, Renin secretion, and Wnt signaling pathways may be closely associated with HF. The NRDEGs may play a role in responding to mechanical stimuli, membrane rafts, cytokine receptor binding, or the necroptosis signaling pathway. The protein-protein interaction (PPI) network identified EGFR, TXN, FASLG, MAPK14, and CASP8 as hub NRDEGs. Furthermore, immune infiltration analysis of CIBERSORT algorithm suggested that M2 macrophages, memory B cells, monocytes, regulatory T cells (Tregs), follicular helper T cells, and gamma delta T cells may participate in the development of HF. The hub NRDEGs, including EGFR, FASLG, and TXN, exhibited significant correlations with various immune cell types. Finally, animal models confirmed that in the HF group, EGFR and FASLG were up-regulated, while TXN was down-regulated. Conclusion: The present findings demonstrate that necroptosis and immune infiltration are associated with the development of HF. This study provides valuable insights and recommendations for the clinical management of HF.
- 1 February 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 2465-2481
Top Cited PapersOpen AccessIdentification of Necroptosis and Immune Infiltration in Heart Failure Through Bioinformatics Analysis
Purpose: Heart failure (HF) remains a leading cause of mortality and morbidity in cardiovascular disease. Research has shown that necroptosis contributes to HF, and immune infiltration has been reported to be implicated in HF. However, the specific mechanisms by which necroptosis and immune infiltration promote HF remain poorly understood. This study aims to elucidate these mechanisms, thereby providing new insights for future therapeutic strategies. Methods and Results: In the GSE21610 dataset, there were 1848 differentially expressed genes (DEGs), 14 of which related to necroptosis (NRDEGs) in HF. Gene Set Enrichment Analysis (GSEA) indicated that Th1 and Th2 cell differentiation, TGF-beta signaling, Renin secretion, and Wnt signaling pathways may be closely associated with HF. The NRDEGs may play a role in responding to mechanical stimuli, membrane rafts, cytokine receptor binding, or the necroptosis signaling pathway. The protein-protein interaction (PPI) network identified EGFR, TXN, FASLG, MAPK14, and CASP8 as hub NRDEGs. Furthermore, immune infiltration analysis of CIBERSORT algorithm suggested that M2 macrophages, memory B cells, monocytes, regulatory T cells (Tregs), follicular helper T cells, and gamma delta T cells may participate in the development of HF. The hub NRDEGs, including EGFR, FASLG, and TXN, exhibited significant correlations with various immune cell types. Finally, animal models confirmed that in the HF group, EGFR and FASLG were up-regulated, while TXN was down-regulated. Conclusion: The present findings demonstrate that necroptosis and immune infiltration are associated with the development of HF. This study provides valuable insights and recommendations for the clinical management of HF.
- Open Access
- 10 October 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (10) , 362
The Association between Fatty Liver Index and Lower Limb Arterial Calcification in Patients with Type 2 Diabetes Mellitus
Background: Peripheral arterial calcification is a prevalent condition in patients with type 2 diabetes mellitus (T2DM), resulting in lower-limb amputation and reduced life quality. Non-alcoholic fatty liver disease (NAFLD), which can be simply evaluated using the fatty liver index (FLI), is closely associated with T2DM development. In this study, we aimed to explore the relationship between FLI and lower limb arterial calcification (LLAC) in T2DM patients and to reveal the value of T2DM patients with NAFLD in predicting the occurrence of LLAC. Methods: A total of 77 T2DM patients with LLAC who underwent comprehensive physical and health examinations, serological examinations, as well as lower limb computed tomography imaging at Sun Yat-sen Memorial Hospital of Sun Yat-sen University between January 2018 and January 2019 were enrolled in this study. The FLI was calculated using body mass index, waist circumference, triglycerides, and γ-glutamyl transferase. Additionally, LLAC was evaluated using computed tomography with the Agatston scoring algorithm. The patients were divided into three groups based on their FLI values: Non-liver disease group (FLI <30, n = 29), borderline-liver disease group (30 ≤ FLI < 60, n = 32), and NAFLD group (FLI ≥60, n = 16). Univariate and multivariate binary logistic regression analyses were employed to investigate the association between FLI and LLAC in T2DM patients. Furthermore, differences in LLAC among groups were analyzed using post-hoc multiple comparisons and ordinal logistic regression model analysis. Results: Univariate and multivariate analyses showed that age and FLI influenced LLAC severity in T2DM patients. Moreover, T2DM patients in the NAFLD group had significantly lower LLAC scores than those in the Non-liver disease group. The correlation analysis showed that FLI was negatively associated with LLAC scores (R = –0.31, p = 0.006), while age was positively associated (R = 0.361, p = 0.001). Conclusions: Our study revealed an inverse relationship between FLI and the degree of LLAC. This indicates that, based on evidence in the current research, NAFLD may not be reliable as a predictor of LLAC in T2DM patients.
- 10 October 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (10) , 362
Open AccessThe Association between Fatty Liver Index and Lower Limb Arterial Calcification in Patients with Type 2 Diabetes Mellitus
Background: Peripheral arterial calcification is a prevalent condition in patients with type 2 diabetes mellitus (T2DM), resulting in lower-limb amputation and reduced life quality. Non-alcoholic fatty liver disease (NAFLD), which can be simply evaluated using the fatty liver index (FLI), is closely associated with T2DM development. In this study, we aimed to explore the relationship between FLI and lower limb arterial calcification (LLAC) in T2DM patients and to reveal the value of T2DM patients with NAFLD in predicting the occurrence of LLAC. Methods: A total of 77 T2DM patients with LLAC who underwent comprehensive physical and health examinations, serological examinations, as well as lower limb computed tomography imaging at Sun Yat-sen Memorial Hospital of Sun Yat-sen University between January 2018 and January 2019 were enrolled in this study. The FLI was calculated using body mass index, waist circumference, triglycerides, and γ-glutamyl transferase. Additionally, LLAC was evaluated using computed tomography with the Agatston scoring algorithm. The patients were divided into three groups based on their FLI values: Non-liver disease group (FLI <30, n = 29), borderline-liver disease group (30 ≤ FLI < 60, n = 32), and NAFLD group (FLI ≥60, n = 16). Univariate and multivariate binary logistic regression analyses were employed to investigate the association between FLI and LLAC in T2DM patients. Furthermore, differences in LLAC among groups were analyzed using post-hoc multiple comparisons and ordinal logistic regression model analysis. Results: Univariate and multivariate analyses showed that age and FLI influenced LLAC severity in T2DM patients. Moreover, T2DM patients in the NAFLD group had significantly lower LLAC scores than those in the Non-liver disease group. The correlation analysis showed that FLI was negatively associated with LLAC scores (R = –0.31, p = 0.006), while age was positively associated (R = 0.361, p = 0.001). Conclusions: Our study revealed an inverse relationship between FLI and the degree of LLAC. This indicates that, based on evidence in the current research, NAFLD may not be reliable as a predictor of LLAC in T2DM patients.
- Open Access
- 22 April 2024
- Published by Springer Nature in BioData Mining
- Vol. 17 (1) , 1-19
Machine-learning-based models to predict cardiovascular risk using oculomics and clinic variables in KNHANES
Background: Recent researches have found a strong correlation between the triglyceride-glucose (TyG) index or the atherogenic index of plasma (AIP) and cardiovascular disease (CVD) risk. However, there is a lack of research on non-invasive and rapid prediction of cardiovascular risk. We aimed to develop and validate a machine-learning model for predicting cardiovascular risk based on variables encompassing clinical questionnaires and oculomics. Methods: We collected data from the Korean National Health and Nutrition Examination Survey (KNHANES). The training dataset (80% from the year 2008 to 2011 KNHANES) was used for machine learning model development, with internal validation using the remaining 20%. An external validation dataset from the year 2012 assessed the model’s predictive capacity for TyG-index or AIP in new cases. We included 32122 participants in the final dataset. Machine learning models used 25 algorithms were trained on oculomics measurements and clinical questionnaires to predict the range of TyG-index and AIP. The area under the receiver operating characteristic curve (AUC), accuracy, precision, recall, and F1 score were used to evaluate the performance of our machine learning models. Results: Based on large-scale cohort studies, we determined TyG-index cut-off points at 8.0, 8.75 (upper one-third values), 8.93 (upper one-fourth values), and AIP cut-offs at 0.318, 0.34. Values surpassing these thresholds indicated elevated cardiovascular risk. The best-performing algorithm revealed TyG-index cut-offs at 8.0, 8.75, and 8.93 with internal validation AUCs of 0.812, 0.873, and 0.911, respectively. External validation AUCs were 0.809, 0.863, and 0.901. For AIP at 0.34, internal and external validation achieved similar AUCs of 0.849 and 0.842. Slightly lower performance was seen for the 0.318 cut-off, with AUCs of 0.844 and 0.836. Significant gender-based variations were noted for TyG-index at 8 (male AUC=0.832, female AUC=0.790) and 8.75 (male AUC=0.874, female AUC=0.862) and AIP at 0.318 (male AUC=0.853, female AUC=0.825) and 0.34 (male AUC=0.858, female AUC=0.831). Gender similarity in AUC (male AUC=0.907 versus female AUC=0.906) was observed only when the TyG-index cut-off point equals 8.93. Conclusion: We have established a simple and effective non-invasive machine learning model that has good clinical value for predicting cardiovascular risk in the general population.
- 22 April 2024
- Published by Springer Nature in BioData Mining
- Vol. 17 (1) , 1-19
Open AccessMachine-learning-based models to predict cardiovascular risk using oculomics and clinic variables in KNHANES
Background: Recent researches have found a strong correlation between the triglyceride-glucose (TyG) index or the atherogenic index of plasma (AIP) and cardiovascular disease (CVD) risk. However, there is a lack of research on non-invasive and rapid prediction of cardiovascular risk. We aimed to develop and validate a machine-learning model for predicting cardiovascular risk based on variables encompassing clinical questionnaires and oculomics. Methods: We collected data from the Korean National Health and Nutrition Examination Survey (KNHANES). The training dataset (80% from the year 2008 to 2011 KNHANES) was used for machine learning model development, with internal validation using the remaining 20%. An external validation dataset from the year 2012 assessed the model’s predictive capacity for TyG-index or AIP in new cases. We included 32122 participants in the final dataset. Machine learning models used 25 algorithms were trained on oculomics measurements and clinical questionnaires to predict the range of TyG-index and AIP. The area under the receiver operating characteristic curve (AUC), accuracy, precision, recall, and F1 score were used to evaluate the performance of our machine learning models. Results: Based on large-scale cohort studies, we determined TyG-index cut-off points at 8.0, 8.75 (upper one-third values), 8.93 (upper one-fourth values), and AIP cut-offs at 0.318, 0.34. Values surpassing these thresholds indicated elevated cardiovascular risk. The best-performing algorithm revealed TyG-index cut-offs at 8.0, 8.75, and 8.93 with internal validation AUCs of 0.812, 0.873, and 0.911, respectively. External validation AUCs were 0.809, 0.863, and 0.901. For AIP at 0.34, internal and external validation achieved similar AUCs of 0.849 and 0.842. Slightly lower performance was seen for the 0.318 cut-off, with AUCs of 0.844 and 0.836. Significant gender-based variations were noted for TyG-index at 8 (male AUC=0.832, female AUC=0.790) and 8.75 (male AUC=0.874, female AUC=0.862) and AIP at 0.318 (male AUC=0.853, female AUC=0.825) and 0.34 (male AUC=0.858, female AUC=0.831). Gender similarity in AUC (male AUC=0.907 versus female AUC=0.906) was observed only when the TyG-index cut-off point equals 8.93. Conclusion: We have established a simple and effective non-invasive machine learning model that has good clinical value for predicting cardiovascular risk in the general population.
- Open Access
- 29 November 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1295463
Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells
SGLT-2 inhibitors, such as empagliflozin, have been shown to reduce the occurrence of cardiovascular events and delay the progression of atherosclerosis. However, its role in atherosclerotic calcification remains unclear. In this research, ApoE−/− mice were fed with western diet and empagliflozin was added to the drinking water for 24 weeks. Empagliflozin treatment significantly alleviated arterial calcification assessed by alizarin red and von kossa staining in aortic roots and reduced the lipid levels, while had little effect on body weight and blood glucose levels in ApoE−/− mice. In vitro studies, empagliflozin significantly inhibits calcification of primary vascular smooth muscle cells (VSMCs) and aortic rings induced by osteogenic media (OM) or inorganic phosphorus (Pi). RNA sequencing of VSMCs cultured in OM with or without empagliflozin showed that empagliflozin negatively regulated the osteogenic differentiation of VSMCs. And further studies confirmed that empagliflozin significantly inhibited osteogenic differentiation of VSMCs via qRT-PCR. Our study demonstrates that empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of VSMCs, which addressed a critical need for the discovery of a drug-based therapeutic approach in the treatment of atherosclerotic calcification.
- 29 November 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1295463
Open AccessEmpagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells
SGLT-2 inhibitors, such as empagliflozin, have been shown to reduce the occurrence of cardiovascular events and delay the progression of atherosclerosis. However, its role in atherosclerotic calcification remains unclear. In this research, ApoE−/− mice were fed with western diet and empagliflozin was added to the drinking water for 24 weeks. Empagliflozin treatment significantly alleviated arterial calcification assessed by alizarin red and von kossa staining in aortic roots and reduced the lipid levels, while had little effect on body weight and blood glucose levels in ApoE−/− mice. In vitro studies, empagliflozin significantly inhibits calcification of primary vascular smooth muscle cells (VSMCs) and aortic rings induced by osteogenic media (OM) or inorganic phosphorus (Pi). RNA sequencing of VSMCs cultured in OM with or without empagliflozin showed that empagliflozin negatively regulated the osteogenic differentiation of VSMCs. And further studies confirmed that empagliflozin significantly inhibited osteogenic differentiation of VSMCs via qRT-PCR. Our study demonstrates that empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of VSMCs, which addressed a critical need for the discovery of a drug-based therapeutic approach in the treatment of atherosclerotic calcification.